VRXA
Veraxa Biotech AG - Post de-SPAC · Healthcare
Insiders bought $135K net in the last 90 days ·0 sellers, 5 buyers· latest Form 4 filed Oct 29, 2026
Insider Buying
$135K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Oct 29, 2026
Gruninger Marc
Veraxa Biotech AG - Post de-SPAC (VRXA) has 5 SEC Form 4 filings (6 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Oct 29, 2026.
Inside the rolling window, 5 insiders at Veraxa Biotech AG - Post de-SPAC reported 6 open-market purchases totaling $135K and no open-market sales. Insiders have net bought $135K over the trailing 6 months. The most recent open-market filing is a purchase of 867 shares by Director Gruninger Marc, dated Oct 27, 2026, worth $850.
- Industry:Biotechnology
- CEO:Christoph Antz
- Employees:8
- HQ:Heidelberg, ZH, DE
- IPO:2026-06-09
| Source | |||||||
|---|---|---|---|---|---|---|---|
Gruninger MarcFirst filing | Director | Purchase | 867 | $850 | Oct 29 | — | SEC ↗ |
Gruninger MarcFirst filing | Director | Purchase | 9,133 | $9K | Oct 29 | — | SEC ↗ |
Ziegler Christoph SamuelFirst filing | Director | Purchase | 30,000 | $33K | Oct 21 | +6.6% | SEC ↗ |
Hosseinion WarrenFirst in 6 months | Director | Purchase | 6,024 | $10K | Sep 29 | -13.7% | SEC ↗ |
Antz Christoph RudigerFirst filing | Chief Executive Officer | Purchase | 5,000 | $8K | Aug 31 | -16.3% | SEC ↗ |
Baumann Oliver RolfFirst filing | Director | Purchase | 50,000 | $75K | Aug 31 | -16.3% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does VRXA have?
Veraxa Biotech AG - Post de-SPAC (VRXA) has 5 SEC Form 4 filings (6 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Oct 29, 2026.
When was the most recent SEC Form 4 filing for VRXA?
The most recent Form 4 filing for VRXA on Tracefour is dated Oct 29, 2026.
What is the net insider flow at VRXA over the last 6 months?
Over the trailing 180 days, insiders at VRXA have net bought $135K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at VRXA in the current window?
Inside the rolling window, insiders at VRXA bought $135K and sold $0 based on SEC Form 4 filings.
Can I get alerts for VRXA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Veraxa Biotech AG - Post de-SPAC (VRXA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Veraxa Biotech AG - Post de-SPAC is in the Healthcare sector.